http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Soon Sun Kim ),( Sun Joo Ahn ),( Sun Young Park ),( Gawon Song Jae ),( Youn Cheong ),( Sung Won Cho ) 대한간학회 2013 춘·추계 학술대회 (KASL) Vol.2013 No.1
Background: To assess the risk for the development of hepatocellular carcinoma (HCC) according to the underlying liver status and virological response (VR) to entecavir (ETV) in chronic hepatitis B patients with cirrhosis. Methods: A total of 324 patients with cirrhosis were treated with ETV for ≥ 6 months and were followed up (mean duration 36.0 months) for the occurrence of HCC. Patients who developed HCC within 6 months were excluded. VR was defined as HBV DNA <2,000 copies/mL until June, 2008 and <20 IU/ mL after July, 2008. Results: Two hundred and twenty (67.9%) patients had compensated cirrhosis and remaining (32.1%) patients had decompensated cirrhosis. The 5-year prevalence of HCC was 28.5%. Univariate analysis showed that increasing age (P=0.002), male gender (P=0.008), diabetes mellitus (P=0.012), hepatic encephalopathy (P=0.017) were risk factors for the development of HCC. VR was related with low probability of developing HCC (P=0.000). Cox regression analysis showed that age over 50 (P=0.000, RR 2.906) and male gender (P=0.005, RR 2.887) were independent risks for the development of HCC. Patients with VR had protective effect for development of HCC (P=0.000, RR 0.056). Conclusions: Antiviral treatment with ETV does not completely eliminate HCC risk in patients with cirrhosis. However, VR to ETV is associated with a lower probability of developing HCC in patients with cirrhosis.
조기 식도암에서 내시경점막하박리술 시행 후 항암방사선동시요법을 시행한 1예
한규현,신선영,문준일,송가원,고원진,김원희,홍성표,조주영,Kyuhyun Han,Sunyoung Shin,Junil Moon,Gawon Song,Wonjin Koh,Wonhee Kim,Sungpyo Hong,Joo Young Cho 대한소화기암연구학회 2015 Journal of digestive cancer reports Vol.3 No.1
62-year-old patient who had past history of endoscopic submucosal dissection for early gastric cancer at September 2008, underwent endoscopic submucosal dissection of esophagus for early esophageal cancer at mid esophagus during health screening service. Because there was a high risk of lymph node metastasis at biopsy results, concurrent chemoradiotherapy was added to endoscopic submucosal dissection. There was a metachronous cancer at mid-esophagus at March 2013. He underwent endoscopic mucosal resection and photodynamic therapy. Concurrentchemoradiotherapy after endoscopic submucosal dissection is an effective treatment method.